Table 2 Shows the quality of life of patients with aspects of fatigue, emotional function, worries, abdominal symptoms, activity and systemic symptoms assessed by CQLD. Patients with ACLF showed a significantly reduced quality of life in terms of worry (4,48 ± 1,3 vs. 3,57 ± 1,2) and systemic symptoms (4,48 ± 1,6 vs. 3,29 ± 1,2)
Parameter | Decompensated liver cirrhosis (N = 42) | Acute-on-chronic liver failure (N = 21) | P Value |
|---|---|---|---|
Fatigue (MEAN; SD) | 3,98 ± 1,12 | 3,76 ± 1,09 | 0,5 |
Emotional Function (MEAN; SD) | 4,24 ± 1,14 | 3,67 ± 1,07 | 0,06 |
Worries (MEAN; SD) | 4,48 ± 1,27 | 3,57 ± 1,17 | 0,008 |
Abdominal symptoms (MEAN; SD) | 4,43 ± 1,4 | 3,9 ± 1,22 | 0,2 |
Activity (MEAN; SD) | 4,43 ± 1,31 | 4,1 ± 1,55 | 0,4 |
Systemic symptoms (MEAN; SD) | 4,48 ± 1,58 | 3,29 ± 1,19 | 0,004 |
Total Quality of Life (MEAN; SD) | 4,33 ± 1,14 | 3,67 ± 0,91 | 0,02 |